Ambarella (AMBA) volatility elevated into Q3 and outlook
- Wall St. set to rise ahead of Trump inauguration
- General Electric (GE) Reports In-Line Q4 EPS
- Procter & Gamble (PG) Tops Q2 EPS by 2c
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Dollar recoups losses, caution sets in ahead of Trump inauguration
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Ambarella (NASDAQ: AMBA) December weekly call option implied volatility is at 108, December is at 67; compared to its 52-week range of 41 to 91 into the expected release of Q3 results on December 1.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stocks with Implied Volatility Movement
- Procter & Gamble (PG) January volatility elevated at 49 into shares rally 2.6% in premarket
- Bristol-Myers Squibb (BMY) volatility low into saying it won’t seek accelerated approval for lung cancer combination treatment
Create E-mail Alert Related CategoriesOptions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!